Astrana Health ASTH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Astrana Health (ASTH)
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
Key Insights
Critical company metrics and information
Latest Closing Price
$29.38Market Cap
$1.40 BillionPrice-Earnings Ratio
86.41Total Outstanding Shares
56.25 Million SharesTotal Employees
1,800Dividend
No dividendIPO Date
June 3, 2015SIC Description
Services-management Consulting ServicesPrimary Exchange
NASDAQType
Common StockHeadquarters
1668 s. garfield avenue, Alhambra, CA, 91801Homepage
https://www.astranahealth.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $22.68 Million |
Net Cash Flow | $22.68 Million |
Net Cash Flow From Financing Activities, Continuing | $-3.19 Million |
Net Cash Flow From Investing Activities | $-8.11 Million |
Net Cash Flow From Operating Activities, Continuing | $33.98 Million |
Net Cash Flow From Operating Activities | $33.98 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Revenues | $478.71 Million |
Preferred Stock Dividends And Other Adjustments | $0 |
Income/Loss From Continuing Operations After Tax | $18.98 Million |
Income Tax Expense/Benefit | $7.83 Million |
Costs And Expenses | $450.29 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $2.89 Million |
Comprehensive Income
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Other Comprehensive Income/Loss | $0 |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Comprehensive Income/Loss Attributable To Parent | $18.98 Million |
Comprehensive Income/Loss | $18.98 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Equity Attributable To Noncontrolling Interest | $5.00 Million |
Noncurrent Assets | $688.39 Million |
Liabilities And Equity | $1.29 Billion |
Current Liabilities | $312.93 Million |
Noncurrent Liabilities | $465.34 Million |
Wages | $17.50 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Recent Headlines From The Web
Latest news, press releases, and media coverage about ASTH from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.